Point72 Middle East Fze Inari Medical, Inc. Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$48.3 - $68.06 $1.37 Million - $1.94 Million	28,444 Added 426.06%	35,120 $2.28 Million
Q3 2023 Nov 14, 2023	SELL	$54.2 - $71.67 $52,790 - $69,806	-974 Reduced 12.73%	6,676 $436,000
Q2 2023 Aug 14, 2023	BUY	$56.23 - $71.17 $298,693 - $378,055	5,312 Added 227.2%	7,650 $444,000
Q1 2023 May 15, 2023	BUY	$53.43 - $68.12 $79,022 - $100,749	1,479 Added 172.18%	2,338 $144,000
Q4 2022 Feb 14, 2023	BUY	$61.23 - $83.62 $52,596 - $71,829	859 New	859 $0

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.77B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.